Press "Enter" to skip to content

Will request US, Europe vaccine authorization Monday: Moderna

Moderna Inc will apply for US and European emergency authorization for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns. Moderna also reported that its vaccine’s efficacy rate was consistent across age, race, ethnicity and gender demographics.
Translate »